ADMT - ADM Tronics Unlimited, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.1889
-0.0003 (-0.16%)
As of 12:04PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close0.1892
Open0.1892
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1889 - 0.1892
52 Week Range0.1000 - 0.2000
Volume1,200
Avg. Volume47,896
Market Cap13.1M
Beta (3Y Monthly)-0.40
PE Ratio (TTM)N/A
EPS (TTM)-0.0100
Earnings DateFeb 21, 2018 - Feb 26, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • ACCESSWIRE

    ADM Tronics Reports First Quarter of Fiscal Year 2020 Results

    NORTHVALE, NJ / ACCESSWIRE / August 19, 2019 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, today announced results for ...

  • GlobeNewswire

    ADM Tronics Announces Alvio Respiratory Technology FCC Certification

    Northvale, NJ, Aug. 12, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- ADM Tronics Unlimited, Inc. (ADMT) announced that the Alvio™ Respiratory Technology it has had under development pursuant to its previously announced agreement with QOL Devices, Inc. ("QOL") has achieved US Federal Communications Commission (“FCC”) certification.   Alvio is a versatile respiratory therapy and training platform targeted for use in respiratory training applications.

  • GlobeNewswire

    ADM Tronics Expands Medical Device Research and Manufacturing Facilities

    Northvale, NJ, July 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- ADM Tronics Unlimited, Inc. (OTCQB: ADMT) is expanding research and manufacturing areas in its Northvale facility due to increased R&D activities and projected increases in customer contract manufacturing orders.  At fiscal year end March 31, 2019 ADMT reported an increase in R&D expenditures of 27% and a backlog of $730,000 in customer orders, which prompted management’s decision to increase R&D and manufacturing areas. The higher R&D expenditures are related to continued development of the Company’s suite of proprietary medical technologies.  In addition to contract R&D and engineering development services for clients, ADMT develops its own proprietary medical technologies.  The Company has recently filed two new patent applications for developments in its medical technologies.

  • ACCESSWIRE

    ADM Tronics Reports Fiscal Year 2019

    NORTHVALE, NJ / ACCESSWIRE / July 15, 2019 / ADM Tronics Unlimited, Inc. (OTCQB: ADMT), a technology-based developer and manufacturer of innovative, proprietary medical technologies, today announced results for fiscal year ended March 31, 2019. Throughout the fiscal year ended March 31, 2019, ADMT continued its strategic plan to devote financial and technological resources to the development of its proprietary medical technologies.

  • GlobeNewswire

    ADM Tronics CEO Andre’ DiMino Interviewed on The Big Biz Show

    Northvale, NJ, March 05, 2019 -- via NEWMEDIAWIRE -- ADM Tronics Unlimited, Inc.  (OTCQB: ADMT), a technology-based developer and manufacturer of innovative technologies and.

  • ACCESSWIRE

    ADM Tronics Reports Third Quarter of Fiscal Year 2019 Results

    NORTHVALE, NJ / ACCESSWIRE / February 19, 2019 / ADM Tronics Unlimited, Inc. (OTCQB: ADMT ), a technology-based developer and manufacturer of innovative technologies and products, today announced results ...

  • ACCESSWIRE

    ADM Tronics Reports Financial Results for Second Quarter of Fiscal Year 2019

    NORTHVALE, NJ / ACCESSWIRE / November 19, 2018 / ADM Tronics Unlimited, Inc. (OTCQB: ADMT ), a technology-based developer and manufacturer of innovative technologies and products, today announced results ...

  • GlobeNewswire

    ADM Tronics Accepted for Membership in MTEC - Medical Technology Enterprise Consortium

    Northvale, NJ, Nov. 08, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- ADM Tronics Unlimited, Inc. (ADMT) has been accepted for membership in the Medical Technology Enterprise Consortium (“MTEC”), a 501(c)3 biomedical technology consortium collaborating with multiple government agencies to foster integrated research partnerships to speed availability of medical technology solutions to the military, veterans and the civilian population. ADMT’s expertise in the research, development and commercialization of therapeutic and diagnostic innovative medical device technologies aligns with the mission and goals of MTEC.  MTEC membership is comprised of a wide range of organizations, including large companies, small businesses, academic research institutions and non-profit organizations.  MTEC facilitates collaboration among its members and government agencies on biomedical research and development across all areas of military medicine.

  • ACCESSWIRE

    ADM Tronics Achieves Development Milestone for Alvio Respiratory Therapy Platform

    NORTHVALE, NJ / ACCESSWIRE / October 15, 2018 / ADM Tronics Unlimited, Inc. (ADMT) has achieved a milestone in the development of the Alvio Respiratory Therapy platform "Alvio™"). ADMT has completed development and engineering to bring Alvio to production-ready status. As announced last November, ADM entered into an agreement with QoL Devices, Inc., a private company ("QoL") for development, regulatory activities and manufacturing of Alvio.